Growth Inhibition and Apoptosis-Inducing Effects of Cudraflavone B in Human Oral Cancer Cells via MAPK, NF-κB, and SIRT1 Signaling Pathway

Abstract

The goal of this study was to investigate the effect and molecular mechanism of cudraflavone B, a prenylated flavonoid isolated from the root bark of Cudrania tricuspidata, against oral squamous cell carcinoma cells. We observed that cudraflavone B inhibited proliferation of these cells in a time- and dose-dependent manner. At 15 µM, cudraflavone B induced cell death via apoptosis (characterized by the appearance of nuclear morphology) and increased the accumulation of the sub-G₁ peak (portion of apoptotic annexin V positive cells). Treatment with cudraflavone B triggered the mitochondrial apoptotic pathway (indicated by induction of the proapoptotic protein p53 and the p21 and p27 effector proteins), downregulation of cell cycle regulatory proteins (e.g., p-Rb, changing Bax/Bcl-2 ratios, cytochrome-c release), and caspase-3 activation. Cudraflavone B time-dependently activated NF-κB, the MAP kinases p38, and ERK, and induced the expression of SIRT1. SIRT1 activator, resveratrol, dose-dependently attenuated the growth-inhibitory and apoptosis-inducing effect of cudraflavone B and blocked cudraflavone B-induced regulatory protein expressions in the mitochondrial pathway such as p53, p21, p27, Bax, caspase-3, and cytochrome-c. Conversely, treatment with SIRT1 inhibitor sirtinol caused opposite effects. These results demonstrate for the first time that the molecular mechanism underlying the antitumor effect in oral squamous cell carcinoma cells is related to the activation of MAPK/and NF-κB as well as of the SIRT1 pathway. Therefore, cudraflavone B may be a lead for the development of a potential candidate for human oral squamous cell carcinoma cells.

Key words

cudraflavone B - Cudrania tricuspidata - Moraceae - oral cancer cell - apoptosis - NF-κB - SIRT1

^* Contributed equally to this work as 1st authors.

• References

• 1 Greenlee RT, Hill-Harmon MB, Murray T. Cancer statistics. CA Cancer J Clin 2001; 51: 15-36
• 2 Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C, Thun MJ. Cancer statistics. CA Cancer J Clin 2006; 56: 106-130
• 3 Carr C, Ng J, Wigmore T. The side effects of chemotherapeutic agents. Curr Anaesth Crit Care 2008; 19: 70-79
• 4 McCann J. Texas center studies research alternative treatments. J Natl Cancer Inst 1997; 89: 1485-1486
• 5 Lee IK, Kim CJ, Song KS, Kim HM, Koshino H, Uramoto M, Yoo ID. Cytotoxic benzyl dihydroflavonols from Cudrania tricuspidata . Phytochemistry 1996; 41: 213-216
• 6 Shougakukan, the dictionary of Chinese drugs, Volume 2. Shanghai: Science and Technological Publisher; 1985: 2383
• 7 Oh H, Ko EK, Jun JY, Oh MH, Park SU, Kang KH, Lee HS, Kim YC. Hepatoprotective and free radical scavenging activities of prenylflavonoids, coumarin, and stilbene from Morus alba . Planta Med 2002; 68: 932-934
• 8 An RB, Sohn DH, Kim YC. Hepatoprotective compounds of the roots of Cudrania tricuspidata on tacrine-induced cytotoxicity in Hep G2 cells. Biol Pharm Bull 2006; 29: 838-840
• 9 Jeong GS, An RB, Pae HO, Chung HT, Yoon KH, Kang DG, Lee HS, Kim YC. Cudratricusxanthone A protects mouse hippocampal cells against glutamate-induced neurotoxicity via the induction of heme oxygenase-1. Planta Med 2008; 74: 1368-1373
• 10 Zou YS, Hou AJ, Zhu GF, Chen YF, Sun HD, Zhao QS. Cytotoxic isoprenylated xanthones from Cudrania tricuspidata . Bioorg Med Chem 2004; 12: 1947-1953
• 11 Arung ET, Yoshikawa K, Shimizu K, Kondo R. Isoprenoid-substituted flavonoids from wood of Artocarpus heterophyllus on B16 melanoma cells: cytotoxicity and structural criteria. Fitoterapia 2010; 81: 120-123
• 12 Hwang JH, Hong SS, Han XH, Hwang JS, Lee DH, Lee HS, Yun YP, Kim YS, Ro JS, Hwang BY. Prenylated xanthones from the root bark of Cudrania tricuspidata . J Nat Prod 2007; 70: 1207-1209
• 13 Kim TJ, Han HJ, Lim Y, Song MC, Kim J, Hong JT, Yoo HS, Pyo MY, Hwang BY, Lee MK, Yun YP. Antiproliferative action of cudraflavone B, isolated from Cudrania tricuspidata, through the downregulation of pRb phosphorylation in aortic smooth muscle cell proliferation signaling. J Cardiovasc Pharmacol 2009; 53: 341-348
• 14 Michan S, Sinclair D. Sirtuins in mammals: insights into their biological function. Biochem J 2007; 404: 1-13
• 15 Lee YM, Shin SI, Shin KS, Lee YR, Park BH, Kim EC. The role of sirtuin 1 in osteoblastic differentiation in human periodontal ligament cells. J Periodontal Res 2011; 46: 712-721
• 16 Kim JJ, Kim SJ, Kim YS, Kim SY, Park SH, Kim EC. The role of SIRT1 on angiogenic and odontogenic potential in human dental pulp cells. J Endod 2012; 38: 899-906
• 17 Lee SI, Min KS, Bae WJ, Lee YM, Lee SY, Lee ES, Kim EC. Role of SIRT1 in heat stress- and lipopolysaccharide-induced immune and defense gene expression in human dental pulp cells. J Endod 2011; 37: 1525-1530
• 18 Lee SI, Park KH, Kim SJ, Kang YG, Lee YM, Kim EC. Mechanical stress-activated immune response genes via Sirtuin 1 expression in human periodontal ligament cells. Clin Exp Immunol 2012; 168: 113-124
• 19 Kim YS, Lee YM, Park JS, Lee SK, Kim EC. SIRT1 modulates high-mobility group box 1-induced osteoclastogenic cytokines in human periodontal ligament cells. J Cell Biochem 2010; 111: 1310-1320
• 20 Park YD, Kim YS, Jung YM, Lee SI, Lee YM, Bang JB, Kim EC. Porphyromonas gingivalis lipopolysaccharide regulates interleukin (IL)-17 and IL-23 expression via SIRT1 modulation in human periodontal ligament cells. Cytokine 2012; 60: 284-293
• 21 Longo VD, Kennedy BK. Sirtuins in aging and age-related disease. Cell 2006; 126: 257-268
• 22 Huffman DM, Grizzle WE, Bamman MM, Kim JS, Eltoum IA, Elgavish A, Nagy TR. SIRT1 is significantly elevated in mouse and human prostate cancer. Cancer Res 2007; 67: 6612-6618
• 23 Ota H, Tokunaga E, Chang K, Hikasa M, Iijima K, Eto M, Kozaki K, Akishita M, Ouchi Y, Kaneki M. Sirt1 inhibitor, Sirtinol, induces senescence-like growth arrest with attenuated Ras-MAPK signaling in human cancer cells. Oncogene 2006; 25: 176-185
• 24 Brown JM, Wouters BG. Apoptosis, p 53, and tumor cell sensitivity to anticancer agents. Cancer Res 1999; 59: 1391-1399
• 25 Wang QM, Jones JB, Studzinski GP. Cyclin-dependent kinase inhibitor p 27 as a mediator of the G1-S phase block induced by 1, 25-dihydroxyvitamin D3 in HL60 cells. Cancer Res 1996; 56: 264-267
• 26 Waxman DJ, Schwartz PS. Harnessing apoptosis for improved anticancer gene therapy. Cancer Res 2003; 15: 8563-8572
• 27 Kim H, Rafiuddin-Shah M, Tu HC, Jeffers JR, Zambetti GP, Hsieh JJ, Cheng EH. Hierarchical regulation of mitochondrion-dependent apoptosis by BCL-2 subfamilies. Nat Cell Biol 2006; 8: 1348-1358
• 28 Meriin AB, Gabai VL, Yaglom J, Shifrin VI, Sherman MY. Proteasome inhibitors activate stress kinases and induce Hsp72. J Biol Chem 1998; 273: 6373-6379
• 29 Huh JE, Kang KS, Chae C, Kim HM, Ahn KS, Kim SH. Roles of p 38 and JNK mitogen-activated protein kinase pathways during cantharidin-induced apoptosis in U937 cells. Biochem Pharmacol 2004; 67: 1811-1818
• 30 Lee YM, Jeong GS, Lim HD, An RB, Kim YC, Kim EC. Isoliquiritigenin 2′-methyl ether induces growth inhibition and apoptosis in oral cancer cells via heme oxygenase-1. Toxicol In Vitro 2010; 24: 776-782
• 31 Lee YM, Kim YC, Choi BJ, Lee DW, Yoon JH, Kim EC. Mechanism of sappanchalcone-induced growth inhibition and apoptosis in human oral cancer cells. Toxicol In Vitro 2011; 25: 1782-1788
• 32 Vargo MA, Voss OH, Foustka F, Cardounel AJ, Grotewold E, Doseff AI. Apigenin-induced-apoptosis is mediated by the activation of PKCδ and caspases in leukemia cells. Biochem Pharmacol 2006; 72: 681-692
• 33 Deorukhkar A, Krishnan S, Sethi G, Aggarwal BB. Back to basics: how natural products can provide the basis for new therapeutics. Expert Opin Invest Drug 2007; 16: 1753-1773
• 34 Li HL, Chen DD, Li XH, Zhang HW, Lu YQ, Ye CL, Ren XD. Changes of NF-kB, p 53, Bcl-2 and caspase in apoptosis induced by JTE-522 in human gastric adenocarcinoma cell line AGS cells: role of reactive oxygen species. World J Gastroenterol 2002; 8: 431-435
• 35 Jeong WS, Kim IW, Hu R, Kong AN. Modulatory properties of various natural chemopreventive agents on the activation of NF-kappaB signaling pathway. Pharm Res 2004; 21: 661-670
• 36 Tano T, Okamoto M, Kan S, Nakashiro K, Shimodaira S, Yamashita N, Kawakami Y, Hamakawa H. Growth inhibition and apoptosis by an active component of OK-432, a streptococcal agent, via Toll-like receptor 4 in human head and neck cancer cell lines. Oral Oncol 2012; 48: 678-685
• 37 Lu MC, Du YC, Chuu JJ, Hwang SL, Hsieh PC, Hung CS, Chang FR, Wu YC. Active extracts of wild fruiting bodies of Antrodia camphorata (EEAC) induce leukemia HL 60 cells apoptosis partially through histone hypoacetylation and synergistically promote anticancer effect of trichostatin A. Arch Toxicol 2009; 83: 121-129
• 38 Kitajima I, Soejima Y, Takasaki I, Beppu H, Tokioka T, Maruyama I. Ceramide-induced nuclear translocation of NF-κB is a potential mediator of the apoptotic response to TNF-α in murine clonal osteoblasts. Bone 1996; 19: 263-270
• 39 Yang J, Wu LJ, Tashiro S, Onodera S, Ikejima T. Nitric oxide activated by p 38 and NF-kappaB facilitates apoptosis and cell cycle arrest under oxidative stress in evodiamine-treated human melanoma A375-S2 cells. Free Radic Res 2008; 42: 1-11
• 40 Wang R, Sengupta K, Li C, Kim H, Cao L, Xiao C, Kim S, Xu X, Zheng Y, Chilton B, Jia R, Zheng Z, Appella E, Wang XW, Ried T, Deng C. Impaired DNA damage response, genome instability, and tumorigenesis in SIRT1 mutant mice. Cancer Cell 2008; 14: 312-323
• 41 Saunders LR, Verdin E. Sirtuins: critical regulators at the crossroads between cancer and aging. Oncogene 2007; 26: 5489-5504
• 42 Dave M, Attur M, Palmer G, Al-Mussawir HE, Kennish L, Patel J, Abramson SB. The antioxidant resveratrol protects against chondrocyte apoptosis via effects on mitochondrial polarization and ATP production. Arthritis Rheum 2008; 58: 2786-2797
• 43 Shakibaei M, John T, Seifarth C, Mobasheri A. Resveratrol inhibits IL-1β-induced stimulation of caspase-3 and cleavage of PARP in human articular chondrocytes in vitro. Ann NY Acad Sci 2007; 1095: 554-563
• 44 Fukui M, Yamabe N, Zhu BT. Resveratrol attenuates the anticancer efficacy of paclitaxel in human breast cancer cells in vitro and in vivo . Eur J Cancer 2010; 46: 1882-1891
• 45 Takayama K, Ishida K, Matsushita T, Fujita N, Hayashi S, Sasaki K, Tei K, Kubo S, Matsumoto T, Fujioka H, Kurosaka M, Kuroda R. SIRT1 regulation of apoptosis of human chondrocytes. Arthritis Rheum 2009; 60: 2731-2740
• 46 Ford J, Jiang M, Milner J. Cancer-specific functions of SIRT1 enable human epithelial cancer cell growth and survival. Cancer Res 2005; 65: 10457-10463
• 47 Kalle AM, Mallika A, Badiger J, Alinakhi, Talukdar P. Sachchidanand. Inhibition of SIRT1 by a small molecule induces apoptosis in breast cancer cells. Biochem Biophys Res Commun 2010; 401: 13-19
• 48 Chang CJ, Hsu CC, Yung MC, Chen KY, Tzao C, Wu WF, Chou HY, Lee YY, Lu KH, Chiou SH, Ma HI. Enhanced radiosensitivity and radiation-induced apoptosis in glioma CD133-positive cells by knockdown of SirT1 expression. Biochem Biophys Res Commun 2009; 380: 236-242
• 49 Cheng HL, Mostoslavsky R, Saito S, Manis JP, Gu Y, Patel P, Bronson R, Appella E, Alt FW, Chua KF. Developmental defects and p 53 hyperacetylation in Sir2 homolog (SIRT1)-deficient mice. Proc Natl Acad Sci USA 2003; 100: 10794-10799
• 50 Cardinali MH, Pietraszkiewicz JF, Robbins KC. Tyrosine phosphorylation as a marker for aberrantly regulated growth-promoting pathways in cell lines derived from head and neck malignancies. Int J Cancer 1995; 61: 98-103
• 51 Johnson GK, Organ GC. Prostaglandin E2 and interleukin-I concentrations in nicotine-exposed oral keratinocyte cultures. J Periodontal Res 1997; 32: 447-454
• 52 Pi SH, Lee SK, Hwang YS, Choi MG, Lee SK, Kim EC. Differential expression of periodontal ligament-specific markers and osteogenic differentiation in HPV16-immortalized human gingival fibroblasts and periodontal ligament cells. J Periodontal Res 2007; 42: 104-113
• 53 Lee J, Lee HJ, Park JD, Lee SK, Lee SI, Lim HD, Lee YM, Yun YG, Jeon BH, Ree IS, Jun CD, Lee SK, Kim EC. Anti-cancer activity of highly purified sulfur in immortalized and malignant human oral keratinocytes. Toxicol In Vitro 2008; 22: 87-95
• 54 Kim EC, Hwang YS, Lee HJ, Lee SK, Park MH, Jeon BH, Jeon CD, Lee SK, Yu HH, You YO. Caesalpinia sappan induces cell death by increasing the expression of p 53 and p 21WAF1/CIP1 in head and neck cancer cells. Am J Chin Med 2005; 33: 405-414
• 55 Lee HJ, Son DH, Lee SK, Lee J, Jun CD, Jeon BH, Lee SK, Kim EC. Extract of Coptidis rhizoma induce cytochrome-c dependent apoptosis in immortalized and malignant human oral keratinocytes. Phytother Res 2006; 20: 773-779
• 56 Chen JC, Lu KW, Tsai ML, Hsu SC, Kuo CL, Yang JS, Hsia TC, Yu CS, Chou ST, Kao MC, Chung JG, Wood WG. Gypenosides induced G0/G1 arrest via CHk2 and apoptosis through endoplasmic reticulum stress and mitochondria-dependent pathways in human tongue cancer SCC-4 cells. Oral Oncol 2009; 45: 273-283
• 57 Yang JS, Chen GW, Hsia TC, Ho HC, Ho CC, Lin MW, Lin SS, Yeh RD, Ip SW, Lu HF, Chung JG. Diallyl disulfide induces apoptosis in human colon cancer cell line (COLO 205) through the induction of reactive oxygen species, endoplasmic reticulum stress, caspases casade (sic) and mitochondrial-dependent pathways. Food Chem Toxicol 2009; 47: 171-179